These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior. Forconi F; Sozzi E; Cencini E; Zaja F; Intermesoli T; Stelitano C; Rigacci L; Gherlinzoni F; Cantaffa R; Baraldi A; Gallamini A; Zaccaria A; Pulsoni A; Gobbi M; Tassi M; Raspadori D; Leoncini L; Rinaldi A; Sabattini E; Bertoni F; Pileri SA; Lauria F Blood; 2009 Nov; 114(21):4696-702. PubMed ID: 19667403 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 in patients with classic and variant hairy cell leukemia. Kreitman RJ; Yu T; James L; Feurtado J; Eager H; Ortiz OS; Gould M; Mauter J; Zhou H; Burbelo PD; Cohen JI; Wang HW; Yuan CM; Arons E Blood Adv; 2023 Dec; 7(23):7161-7168. PubMed ID: 37729613 [TBL] [Abstract][Full Text] [Related]
10. Update on the biology and treatment options for hairy cell leukemia. Jain P; Pemmaraju N; Ravandi F Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320 [TBL] [Abstract][Full Text] [Related]
11. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia. Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558 [TBL] [Abstract][Full Text] [Related]
12. A Case of Hairy Cell Leukemia Variant: Literature Analysis With Focus on Unmet Needs. Kumar Upadhyay A; Kumar M; Prasad A; Shekhar S; Singh R Cureus; 2023 Oct; 15(10):e47085. PubMed ID: 38022018 [TBL] [Abstract][Full Text] [Related]
13. Expression of the muscle-associated gene MYF6 in hairy cell leukemia. Arons E; Zhou H; Sokolsky M; Gorelik D; Potocka K; Davies S; Fykes E; Still K; Edelman DC; Wang Y; Meltzer PS; Raffeld M; Wiestner A; Xi L; Wang HW; Stetler-Stevenson M; Yuan C; Kreitman RJ PLoS One; 2020; 15(2):e0227586. PubMed ID: 32040482 [TBL] [Abstract][Full Text] [Related]
15. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial. Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277 [TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukaemia-variant: Disease features and treatment. Matutes E; Martínez-Trillos A; Campo E Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904 [TBL] [Abstract][Full Text] [Related]
17. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233 [TBL] [Abstract][Full Text] [Related]
18. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712 [TBL] [Abstract][Full Text] [Related]
19. Cladribine in hairy cell leukemia. Belani R; Saven A Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111 [TBL] [Abstract][Full Text] [Related]
20. No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant. King AC; Kabel CC; Pappacena JJ; Stump SE; Daley RJ Ann Pharmacother; 2019 Sep; 53(9):922-932. PubMed ID: 30841702 [No Abstract] [Full Text] [Related] [Next] [New Search]